DavidRRepaskeMD

PubMed

• Implementation of type 1 diabetes genetic risk screening in children in diverse communities: the Virginia PrIMeD project.
  Guertin, K., Repaske, D., Taylor, J., Williams, E., Onengut-Gumuscu, S., Chen, W., Boggs, S., Yu, L., Allen, L., Botteon, L., Daniel, L., Keating, K., Labergerie, M., ...> ;Genome Medicine. 2024 Feb 14
• 1 citations
  Precision Medicine in Type 1 Diabetes.
  Dominika A Michalek, Suna Onengut-Gumuscu, David R Repaske, Stephen S Rich> ;Journal of the Indian Institute of Science. 2023 Jan 1
• 10 citations
  No central adrenal insufficiency found in patients with Prader-Willi syndrome with an overnight metyrapone test.
  Kathryn Obrynba, Robert P. Hoffman, David R. Repaske, Kathryn Anglin, Manmohan K. Kamboj> ;Journal of Pediatric Endocrinology & Metabolism. 2018 Jul 26
• 11 citations
  Medication-induced diabetes mellitus.
  David R. Repaske> ;Pediatric Diabetes. 2016 Sep 1
• Metabolic Syndrome in Adolescents.
  Manmohan K. Kamboj, David R. Repaske> ;Adolescent Medicine. 2014 Aug 1
• 15 citations
  United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood
  Charmian A. Quigley, Anthony Zagar, Charlie Chunhua Liu, David M. Brown, Carol Huseman, Lynne Levitsky, David R. Repaske, Eva Tsalikian, John J. Chipman> ;International Journal of Pediatric Endocrinology. 2013 Feb 13
• 24 citations
  Outcomes of Adenotonsillectomy in Patients With Prader-Willi Syndrome
  Stacy L. Meyer, Mark Splaingard, David R. Repaske, William Zipf, Joan Atkins, Kris R. Jatana> ;Archives of Otolaryngology--Head & Neck Surgery. 2012 Nov 1
• 3 citations
  Reduction in hypoglycemic events in critically ill patients on continuous insulin following implementation of a treatment guideline.
  Ranjit S. Chima, Pamela J. Schoettker, Kartik Varadarajan, Elizabeth Kloppenborg, Tamara K. Hutson, Richard J. Brilli, David R. Repaske, Michael Seid> ;Quality Management in Health Care. 2012 Jan 1
• 34 citations
  Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes
  Lisa M. Ingerski, Lori M.B. Laffel, Dennis Drotar, David R Repaske, Korey K. Hood> ;Pediatric Diabetes. 2010 Dec 1
• 23 citations
  Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes.
  Sandra Cortina, David R Repaske, Korey K. Hood> ;Pediatric Diabetes. 2009 Sep 16
• 95 citations
  Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes Mediational role of blood glucose monitoring
  Meghan E. McGrady, Lori M.B. Laffel, Dennis Drotar, David R Repaske, Korey K. Hood> ;Diabetes Care. 2009 May 1
• 1 citations
  Making the transition from pediatric to adult endocrinology services.
  David R Repaske, Stuart Handwerger> ;Nature Clinical Practice. Endocrinology & Metabolism. 2008 Jul 1
• 117 citations
  mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain
  Wilma C. G. van Staveren, Harry W.M. Steinbusch, Marjanne Markerink-van Ittersum, David R. Repaske, Michael F. Goy, Jun Kotera, Kenji Omori, Joseph A. Beavo, Jan de Vente> ;The Journal of Comparative Neurology. 2003 Dec 22
• 16 citations
  A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus.
  Jeerunda Santiprabhob, James E. Browning, David R. Repaske> ;Molecular Genetics and Metabolism. 2002 Sep 1
• 99 citations
  Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spat...
  Tracy M. Reed, David R. Repaske, Gretchen L. Snyder, Paul Greengard, Charles V. Vorhees> ;The Journal of Neuroscience. 2002 Jun 15
• 16 citations
  Nine novel mutations in NR0B1 (DAX1) causing adrenal hypoplasia congenita.
  Yao-Hua Zhang, Bing-Ling Huang, Kwame Anyane-Yeboa, Julienne A.R. Carvalho, Robert D. Clemons, Trevor Cole, Bonald C. Figueiredo, Mark S. Lubinsky, Daniel Metzger, Rob...> ;Human Mutation. 2001 Dec 1
• 13 citations
  Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia.
  Jennifer L. King, John M. Naber, Robert J. Hopkin, David R. Repaske, Laurie Bailey, Nancy D. Leslie> ;Archives of Pediatrics & Adolescent Medicine. 2001 Sep 1
• 22 citations
  A missense mutation encoding cys67 → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus
  Linda A. DiMeglio, Priscila C. Gagliardi, James E. Browning, Charmian A. Quigley, David R. Repaske> ;Molecular Genetics and Metabolism. 2001 Jan 1
• 17 citations
  GENOMIC STRUCTURE AND CHROMOSOME LOCATION OF THE MURINE PDE1B PHOSPHODIESTERASE GENE
  Tracey M. Reed, James E. Browning, Ruthann I. Blough, Charles V. Vorhees, David R. Repaske> ;Mammalian Genome. 1998 Jul 1
• 38 citations
  Autosomal Dominant Neurohypophyseal Diabetes Insipidus Associated with a Missense Mutation Encoding Gly23→Val in Neurophysin II
  Priscila C. Gagliardi, Sergio Bernasconi, David R. Repaske> ;The Journal of Clinical Endocrinology and Metabolism. 1997 Nov 1
• 56 citations
  Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of th...
  David R. Repaske, Rita Medlej, Ebrû K. Gültekin, M.R.S. Krishnamani, George Halaby, James W. Findling, John A. Phillips> ;The Journal of Clinical Endocrinology and Metabolism. 1997 Jan 1
• 16 citations
  Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus.
  David R. Repaske, Marshall L. Summar, M.R.S. Krishnamani, E K Gültekin, Maria Cristina Arriazu, Martin Roubicek, M Blanco, Gabriel B Isaac, J A Phillips> ;The Journal of Clinical Endocrinology and Metabolism. 1996 Jun 1
• 30 citations
  A de novo mutation in the coding sequence for neurophysin-II (Pro24-->Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes in...
  David R. Repaske, J E Browning> ;The Journal of Clinical Endocrinology and Metabolism. 1994 Aug 1
• 47 citations
  A polymerase chain reaction strategy to identify and clone cyclic nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA encoding the 63-kDa calmodulin-depe...
  David R. Repaske, Johannes V. Swinnen, S.-L. C. Jin, J J Van Wyk, Marco Conti> ;The Journal of Biological Chemistry. 1992 Sep 15
• 8 citations
  The molecular biology of human hereditary central diabetes insipidus.
  David R. Repaske, John A. Phillips> ;Progress in Brain Research. 1992 Jan 1
• Join now to see all